| Title | Author(s) | Year | View Count |
 | Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? | Wong, H; Wong, KP; Yau, T; Tang, V; Leung, R; Chiu, J; Lang, BHH | 2012 | 78 |
 | Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer | Wong, H; Lau, S; Leung, R; Chiu, J; Cheung, P; Wong, TT; Liang, R; Epstein, RJ; Yau, T | 2012 | 63 |
| The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: A retrospective analysis of efficacy, safety, and survival benefits | Chiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Chan, AC; Pang, R; Fan, ST; Poon, R; Yau, T | 2012 | 81 |
 | Ki67 proliferation index in invasive lobular carcinoma of the breast: clinicopathologic correlation and prognostic significance | Wong, H; Lau, S; Cheung, P; Leung, R; Chiu, J; Wong, TT; Liang, R; Epstein, RJ; Yau, TCC | 2012 | 179 |
| Comparison of clinicopathologic features of invasive lobular carcinoma of the breast with or without associated lobular carcinoma in-situ | Yau, TCC; Wong, H; Lau, S; Leung, R; Chiu, J; Wong, TT; Liang, R; Epstein, RJ; Cheung, P | 2012 | 58 |
| Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy | Leung, R; Lang, B; Wong, H; Chiu, J; Wan, KY; Shek, T; Woo, YC; Lo, CY; Yau, T | 2012 | 50 |
| The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (hcc) | Wong, H; Tang, YF; Yao, TJ; Chiu, J; Leung, R; Chan, P; Cheung, TT; Chan, AC; Pang, RW; Poon, R; Fan, ST; Yau, T | 2011 | 134 |
| Presence of an in-situ component predicts reduced tumor aggressiveness in luminal subtype of invasive breast cancer | Wong, H; Leung, RCY; Lau, S; Chiu, J; Cheung, P; Wong, T; Liang, R; Epstein, R; Yau, T | 2011 | 149 |
| Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study | Yau, T; Leung, RC; Wong, H; Chiu, J; Chan, P; Pang, R; Fan, ST; Poon, RTP | 2011 | 163 |
| The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis | Chiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Poon, RTP; Fan, ST; Yau, CC | 2011 | 192 |
| Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract) | Yau, TCC; Leung, RCY; Wong, H; Chiu, J; Chan, P; Pang, RWC; Fan, ST; Poon, RTP | 2011 | 186 |
| Proteomic analysis of human pluripotent cells | Lau, AT; Xu, YM; Chiu, J | 2011 | 17 |
| Integrating molecular mechanisms and clinical evidence in the management of Trastuzumab resistant or refractory Her-2 + metastatic breast cancer | Wong, H; Leung, R; Kwong, A; Chiu, J; Liang, R; Swanton, C; Yau, T | 2011 | 82 |
| Complications of traditional Chinese/herbal medicines (TCM)-a guide for perplexed oncologists and other cancer caregivers | Chiu, J; Yau, T; Epstein, RJ | 2009 | 93 |
| Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model | Chiu, K; Zhou, Y; Yeung, SC; Lok, CKM; Chan, OOC; Chang, RCC; So, KF; Chiu, J | 2009 | 100 |
| Oligodeoxynucleotide decoy therapy blocks type 1 procollagen transcription and the prolyl hydroxylase b subunit translation | Lok, CN; Ehrlich, HP; White, SL; Buttolph, TR; Cultroneo, KR; Chiu, J | 2008 | 110 |
| Proteomic analysis of the anticancer mechanism of astaxanthin | Sun, Z; Chiu, J; Chen, SF | 2007 | 112 |
| Proteomics approach to study the cytotoxicity of Tubeimoside I | Xu, Y; Chiu, J; He, Q; Chen, SF | 2007 | 215 |
| Proteomic analysis of the mode of antibacterial action of silver nanoparticles | Chiu, J; Lok, CN; Ho, CM; Chen, R; He, Q; Yu, WY; Tam, PKH; Che, CM | 2007 | 272 |
| Topical delivery of silver nanoparticles reduces systemic inflammation of burn and promotes wound healing | Wong, KKY; Tian, J; Ho, CM; Lok, CN; Che, CM; Chiu, J; Tam, PKH | 2006 | 488 |
|
